Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6986 stock hub

TPEX/6986 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6986is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6986

In the news

Latest news · TPEX/6986

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E25.5

P25 14.4P50 18P75 31.9

ROE16.4

P25 -16.2P50 0.3P75 9.8

ROIC40.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6986 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

TWD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	53
Employees Change	8%
Employees Change Percent	17.78
Enterprise value	TWD 2.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006986003
Last refreshed	2026-05-10
Market cap	TWD 2.9B
Price	TWD 61.8
Price currency	TWD
Rev Per Employee	5,532,547.17x
Sector	Healthcare
Sic	8731
Symbol	tpex/6986
Website	https://www.hexunbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	21.26x
EV/EBIT	20.16x
EV/EBITDA	16.3x
EV/FCF	17.41x
EV/Sales	8.11x
FCF yield	4.79%
P/B ratio	3.85x
P/E ratio	25.51x
P/S ratio	9.73x
PE Ratio3 Y	57.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.24%
EBITDA Margin	48.32%
FCF margin	46.59%
Gross margin	90.81%
Gross Profit	TWD 266.3M
Gross Profit Growth	2.15%
Gross Profit Growth Q	4.91%
Gross Profit Growth3 Y	81.4%
Net Income	TWD 111.9M
Net Income Growth	-23.99%
Net Income Growth Q	-1.07%
Net Income Growth Years	0%
Pretax Margin	42.95%
Profit Margin	38.16%
Profit Per Employee	TWD 2.1M
Profitable Years	3
ROA	9.55
ROCE	15.24
ROE	16.43
ROIC	40.82
Roic5y	15.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.5%
EPS Growth	-24.06
EPS Growth Q	-1.24
EPS Growth Years	0
FCF Growth	63.36%
FCF Growth Q	-55.37%
FCF Growth3 Y	139.04%
OCF Growth	35.54%
OCF Growth Q	-36.8%
OCF Growth3 Y	144.39%
Revenue Growth	2.38x
Revenue Growth Q	2.9x
Revenue Growth Years	3x
Revenue Growth3 Y	80.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.38
Assets	TWD 837.1M
Cash	TWD 509.6M
Current Assets	TWD 609.6M
Current Liabilities	TWD 62.5M
Debt	TWD 36.6M
Debt EBITDA	TWD 0.25
Debt Equity	TWD 0.05
Debt FCF	TWD 0.27
Equity	TWD 741.6M
Interest Coverage	105.9
Liabilities	TWD 95.5M
Long Term Assets	TWD 227.5M
Long Term Liabilities	TWD 32.9M
Net Cash	TWD 473.1M
Net Cash By Market Cap	TWD 16.59
Net Cash Growth	39.97%
Net Debt EBITDA	TWD -3.34
Net Debt Equity	TWD -0.64
Net Debt FCF	TWD -3.46
Tangible Book Value	TWD 720.7M
Tangible Book Value Per Share	TWD 15.67
WACC	3.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.75
Inventory Turnover	2.5
Net Working Capital	TWD 41.4M
Quick ratio	9.35
Working Capital	TWD 547.1M
Working Capital Turnover	TWD 0.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%
Dividend per share	TWD 0.22
Dividend Yield	0.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.49%
200-day SMA	61.52
50-day SMA	58.81
50-day SMA vs 200-day SMA	50under200
All Time High	99
All Time High Change	-37.58%
All Time High Date	2023-09-07
All Time Low	40
All Time Low Change	54.5%
All Time Low Date	2024-03-14
ATR	1.82
Beta	-0.08
Beta1y	0.17
Beta2y	0.1
Ch YTD	-1.9
High	62.3
High52	78.6
High52 Date	2025-06-12
High52ch	-21.37%
Low	61.8
Low52	50
Low52 Date	2026-03-04
Low52ch	23.6%
Ma50ch	5.09%
Price vs 200-day SMA	0.46%
RSI	53.25
RSI Monthly	44.41
RSI Weekly	50.62
Sharpe ratio	-0.55x
Sortino ratio	-0.76
Total Return	0.38%
Tr YTD	-1.9
Tr1m	4.92%
Tr1w	-0.64%
Tr3m	5.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 118M
Operating Income Growth	-24.23
Operating Income Growth Q	-20.62
Operating margin	40.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,637,500%
Net Borrowing	-3,807,000
Shares Insiders	32.64%
Shares Out	46,000,000
Shares Qo Q	0.05%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 133M
Average Volume	111,120.15x
Bv Per Share	16.12
CAPEX	TWD -27.3M
Ch1m	4.92
Ch1w	-0.64
Ch1y	-16.49
Ch3m	5.46
Ch6m	17.71
Change	-0.48%
Change From Open	-0.48
Close	62.1
Days Gap	0
Depreciation Amortization	23,675,000
Dollar Volume	2,360,760
Earnings Date	2026-08-13
EBIT	TWD 118M
EBITDA	TWD 141.7M
EPS	TWD 2.43
F Score	5
FCF	TWD 136.6M
FCF EV Yield	5.74x
FCF Per Share	TWD 2.97
Financing CF	1,689,000
Fiscal Year End	December
Founded	2,019
Graham Number	29.68927
Graham Upside	-51.96
Income Tax	TWD 14M
Investing CF	-158,378,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	59.35
Ma150ch	4.12%
Ma20	62.29
Ma20ch	-0.78%
Net CF	7,205,000
Next Earnings Date	2026-08-13
Open	62.1
P FCF Ratio	20.88
P OCF Ratio	17.4
Position In Range	0
Ppne	148,216,000
Price Date	2026-05-08
Price EBITDA	TWD 20.13
Ptbv Ratio	3.96
Relative Volume	0.33x
Revenue	293,225,000x
SBC By Revenue	1.23x
Share Based Comp	3,615,000
Tax By Revenue	4.78x
Tax Rate	11.13%
Tr6m	17.71%
Volume	38,200
Z Score	21.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6986 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.22 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

Annualized growth of the per-share dividend

Total shareholder yield

+0.4%

Dividend yield + buyback yield combined

Performance

TPEX/6986 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6986?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+32.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

TPEX/6986 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.2

Neutral momentum band

Price vs 200-day MA

+0.5%

50/200-day relationship not available

Beta (5Y)

-0.08

Less volatile than the market

Sharpe ratio

-0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6986

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6986 stock rating?

tpex/6986 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6986 analysis?

The full report lives at /stocks/tpex/6986/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6986?

The latest report frames tpex/6986 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6986 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.